VCPIP1, short for Valosin-Containing Protein (VCP)/p97-Interacting Protein 1, is a crucial player in cellular functions due to its involvement in protein homeostasis and multiple degradation pathways. As a deubiquitinating enzyme, it regulates the ubiquitin-proteasome system, an essential process in maintaining cellular health by breaking down unnecessary or damaged proteins.VCPIP1 interacts with VCP, an ATPase associated with diverse cellular activities (AAA-ATPase), forming a complex that plays a vital role in endoplasmic reticulum-associated degradation (ERAD). This process is crucial for the removal of misfolded or malfunctioning proteins within the endoplasmic reticulum, thereby maintaining the organelle's function and inhibitng cellular stress.
Furthermore, VCPIP1 is involved in the regulation of intracellular trafficking and endocytic pathways. It participates in the sorting of endosomal cargoes and their subsequent transport, which is vital for proper cell signaling and homeostasis. Its role in the endocytic pathway suggests a potential influence on receptor down-regulation and antigen processing.VCPIP1 also contributes to the regulation of inflammation and immunity. It has been implicated in the negative regulation of nuclear factor kappa B (NF-kB), a protein complex that controls DNA transcription and is critical in cellular responses to stimuli such as stress and infection.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG132 is a proteasome inhibitor that can potentially increase the need for alternative protein degradation pathways, indirectly enhancing VCPIP1 activity. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $165.00 $575.00 | 60 | |
Lactacystin is a specific inhibitor of the proteasome, potentially increasing ubiquitinated proteins, which may indirectly enhance VCPIP1 function. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $280.00 | 1 | |
MLN4924 inhibits the NEDD8-activating enzyme, affecting protein degradation pathways and possibly influencing VCPIP1 activity. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine, known for lysosomal inhibition, can affect autophagy and may indirectly influence VCPIP1 activity. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $56.00 $256.00 | 113 | |
3-Methyladenine is an inhibitor of autophagy and can influence protein degradation pathways, potentially affecting VCPIP1. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic Acid, a histone deacetylase inhibitor, can influence gene expression and protein degradation pathways, potentially affecting VCPIP1. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, affecting protein folding and degradation, potentially influencing VCPIP1 activity. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $38.00 $58.00 $102.00 $202.00 | 8 | |
Geldanamycin, an HSP90 inhibitor, can impact protein folding and degradation pathways, potentially affecting VCPIP1. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $115.00 $337.00 | 3 | |
Betulinic Acid is known to induce autophagy and may influence protein degradation pathways relevant to VCPIP1. | ||||||